Intellia Therapeutics (NTLA) Prepaid Assets (2015 - 2026)
Intellia Therapeutics (NTLA) reported Prepaid Assets of $81.3 million for Q1 2026, up 118.98% year-over-year from $37.1 million in Q1 2025, and up 18.98% quarter-over-quarter from $68.4 million in Q4 2025.
Intellia Therapeutics (NTLA) Prepaid Assets (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has 12 years of Prepaid Assets data on file, last reported at $81.3 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $81.3 million, up 118.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.3 million (up 118.98% YoY), and the FY2025 annual result was $68.4 million, up 129.15% from the prior year.
- Prepaid Assets advanced to $81.3 million in Q1 2026 per NTLA's latest filing, from $68.4 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $81.3 million in Q1 2026 and troughed at $18.3 million in Q2 2022.
- A 5-year average of $40.3 million and a median of $36.8 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets surged 143.3% in 2023, then slumped 39.92% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $20.4 million in 2022, then jumped by 143.3% to $49.7 million in 2023, then tumbled by 39.92% to $29.8 million in 2024, then surged by 129.15% to $68.4 million in 2025, then rose by 18.98% to $81.3 million in 2026.
- Business Quant data shows NTLA's Prepaid Assets at $81.3 million in Q1 2026, $68.4 million in Q4 2025, and $59.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Intellia Therapeutics | 1.86 Bn | 1.86 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.33 Mn |
| Dec 31, 2025 | 68.36 Mn |
| Sep 30, 2025 | 59.85 Mn |
| Jun 30, 2025 | 36.83 Mn |
| Mar 31, 2025 | 37.14 Mn |
| Dec 31, 2024 | 29.83 Mn |
| Sep 30, 2024 | 43.93 Mn |
| Jun 30, 2024 | 53.81 Mn |
| Mar 31, 2024 | 56.32 Mn |
| Dec 31, 2023 | 49.65 Mn |
| Sep 30, 2023 | 32.21 Mn |
| Jun 30, 2023 | 26.49 Mn |
| Mar 31, 2023 | 25.22 Mn |
| Dec 31, 2022 | 20.41 Mn |
| Sep 30, 2022 | 26.73 Mn |
| Jun 30, 2022 | 18.30 Mn |
| Mar 31, 2022 | 18.32 Mn |
| Dec 31, 2021 | 18.58 Mn |
| Sep 30, 2021 | 14.02 Mn |
| Jun 30, 2021 | 18.39 Mn |